This interview was originally conducted by and published on CHIMECAST.
Healthcare leaders rarely suffer from a shortage of ambitious ideas. The harder challenge is deciding which ones deserve investment and turning those choices into measurable results. Russ Branzell, President and CEO of CHIME, welcomes Peyman Zand, Chief Strategy Officer at CereCore, for a conversation about what separates a compelling strategy from one that actually delivers.
From allocating finite resources and realizing greater value from existing technology investments to creating governance that accelerates rather than restricts innovation, they examine the decisions behind sustainable enterprise performance. Peyman also explores the growing strategic implications of AI and what leaders must protect when possibility, profitability, and responsibility don't neatly align.